guest ::
| Home > Publications database > A Novel Signaling Driven by the Stem Cell Marker ALDH1A3 Promotes Glioblastoma Cell Mobility. |
| Home > Publications database > A Novel Signaling Driven by the Stem Cell Marker ALDH1A3 Promotes Glioblastoma Cell Mobility. |
| Journal Article | DKFZ-2026-01561 |
; ; ; ; ; ; ; ;
2026
MDPI
Basel
Abstract: Glioblastoma (GBM) is an extremely invasive and incurable tumor. We previously reported predominant ALDH1A3 expression at the invasive front of GBM tumors, which was associated with shorter patient survival, and further showed that ALDH1A3 promoted tumor angiogenesis involving plasminogen activator inhibitor-1 (PAI-1). Here, we investigated whether ALDH1A3 drives cell invasion through retinoic acid (RA) and PAI-1 signaling. Analysis of the TCGA-GBM dataset revealed a positive association between ALDH1A3 and PAI-1 (SERPINE1) expression. Overexpression of ALDH1A3 in GBM cells markedly increased PAI-1 mRNA and protein levels, with cellular colocalization of both proteins, accompanied by robust migration and invasion. These effects were reversed by treatment with a pan-RA receptor (RAR) antagonist AGN193109 (AGN), with a specific PAI-1 inhibitor tiplaxtinin (Tip) or by CRISPR/Cas9-mediated knockout of PAI-1. In a chick chorioallantoic membrane (CAM) model, ALDH1A3-overexpressing cells showed increased invasion, which was reduced by tiplaxtinin (Tip) treatment or PAI-1 knockout. Mechanistically, ChIP-qPCR demonstrated that RA treatment or ALDH1A3 overexpression increased RARα occupancy at the PAI-1 regulatory region, accompanied by increased PAI-1 expression, both of which were diminished by AGN. Collectively, the present study defines an ALDH1A3-RA-PAI-1 signaling axis that contributes to GBM cell motility and invasion.
Keyword(s): Humans (MeSH) ; Glioblastoma: pathology (MeSH) ; Glioblastoma: metabolism (MeSH) ; Glioblastoma: genetics (MeSH) ; Cell Movement: drug effects (MeSH) ; Signal Transduction (MeSH) ; Cell Line, Tumor (MeSH) ; Tretinoin: metabolism (MeSH) ; Tretinoin: pharmacology (MeSH) ; Animals (MeSH) ; Aldehyde Oxidoreductases: metabolism (MeSH) ; Aldehyde Oxidoreductases: genetics (MeSH) ; Plasminogen Activator Inhibitor 1: metabolism (MeSH) ; Plasminogen Activator Inhibitor 1: genetics (MeSH) ; Neoplastic Stem Cells: metabolism (MeSH) ; Neoplastic Stem Cells: pathology (MeSH) ; Neoplasm Invasiveness (MeSH) ; Gene Expression Regulation, Neoplastic (MeSH) ; Brain Neoplasms: pathology (MeSH) ; Brain Neoplasms: metabolism (MeSH) ; Brain Neoplasms: genetics (MeSH) ; ALDH1A3 ; CRISPR/Cas9 ; PAI-1 ; glioblastoma ; invasion ; migration ; retinoic acid and retinoic acid receptors ; Tretinoin ; aldehyde dehydrogenase (NAD(P)+) ; Aldehyde Oxidoreductases ; Plasminogen Activator Inhibitor 1
; 
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
